References
Shastry BS (2011) Genetic risk in the development of advanced retinopathy of prematurity. CML Ophthalmol 21:89–96
Shastry BS (2010) Genetic susceptibility to advanced retinopathy of prematurity. J Biomed Sci 17:69–75
Pierce EA, Foley ED, Smith LEH (1996) Regulation of Vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114:1219–1228
Alon T, Hemo I, Itin A, Peer J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024–1028
Vannay A, Dunai G, Banyasz I, Szabo M, Vamos R, Treszl A, Hajdu J, Tulassay T, Vasarhelyi B (2005) Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 57:396–398
Dunai G, Vasarhelyi B, Szabo M, Hajdu J, Meszaros G, Tulassay T, Treszl A (2008) Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity. Curr Eye Res 33:501–505
Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vas Res 37:443–448
Abe A, Sato K, Habuchi T, Wang L, Li Z, Tsuchiya N, Ohyama C, Satoh S, Ogawa S, Kato T (2002) Single nucleotide polymorphisms in the 3’- untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 198:181–190
Cooke RW, Drury JAQ, Mountford R, Clark D (2004) Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 45:1712–1715
Kusuda T, Hikino S, Ohga S, Kinjo T, Ochiai M, Takahata Y, Tokunaga S, Ihara K, Hata Y, Hara T (2011) Genetic variation of vascular endothelial growth factor pathway does not correlate with the severity of retinopathy of prematurity. J Perinatol 31:246–250
Acknowledgement
We would like to thank Dr. Michael T. Trese of William Beaumont Hospital, Royal Oak, MI, USA for providing blood samples from patients and normal individuals. This work was supported by Oakland University Research Grant GRC # 23580.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gismondi, D., Ndoja, L., Qu, X. et al. Lack of association of VEGF gene 3’- UTR polymorphisms (C702T, C936T and G1612A) and the risk of developing advanced retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol 251, 413–415 (2013). https://doi.org/10.1007/s00417-011-1913-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-011-1913-4